Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the first quarter of 2022.
In this edition, COVID cases are still endemic for insurance companies, kids’ contracts are voidable but not void, and crypto can’t escape the Securities Act. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the first quarter.
Class Action MDL Roundup
July 13, 2022
Class Action & MDL Roundup – Q1 2022
- Cari K. Dawson
- David Venderbush
- Ryan P. Ethridge
- David Carpenter
- F. Nicholas Chandler
- Sean R. Crain
- Jamie S. George
- Bradley Harder
- Michelle Jackson
- Jyoti Jindal Kottamasu
- Laura A. Komarek
- Matthew D. Lawson
- Andrew J. Liebler
- William J. Repko III
- Noelle Reyes
- Jason Rottner
- Troy A. Stram
- Ellie Saathoff
- Andrew T. Sumner
- Amanda M. Waide
- Nick A. Young
Meet the Authors
Senior Associate
Phone:
+1 404 881 7969
Other Phone:
+1 212 905 9156
Email:
nick.chandler@alston.com
Related News & Insights
-
Class Action MDL Roundup Spring 2021Class Action & MDL Roundup – Spring 2021Welcome to the spring edition of the Class Action & MDL Roundup, covering significant decisions and settlements from the first quarter of 2021.
-
Class Action MDL Roundup Winter 2021Class Action & MDL Roundup – Winter 2021Welcome back to the Class Action & MDL Roundup! Our winter edition covers notable class actions from the fourth quarter of 2020.
-
Class Action MDL Roundup Summer 2020Class Action & MDL Roundup – Summer 2020Welcome to the summer edition of the Class Action & MDL Roundup, covering significant decisions and settlements from the second quarter of 2020. We also include new class actions popping up in the wake of the COVID-19 pandemic.
-
Class Action MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup June 30, 2023Class Action & MDL Roundup 2023 Q1 – We don’t discount confidentialityIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2023, in pork we antitrust, paid time off is not pay, and if it’s free, it won’t cost you a TCPA violation. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact